Medtronic (MDT) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

MDT Stock Forecast

Medtronic stock forecast is as follows: an average price target of $107.91 (represents a 28.30% upside from MDT’s last price of $84.11) and a rating consensus of 'Hold', based on 18 wall street analysts offering a 1-year stock forecast.

MDT Price Target

The average price target for Medtronic (MDT) is $107.91 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $165.00 to $80.00. This represents a potential 28.30% upside from MDT's last price of $84.11.

MDT Analyst Ratings

Hold

According to 18 Wall Street analysts, Medtronic's rating consensus is 'Hold'. The analyst rating breakdown for MDT stock is 0 'Strong Buy' (0.00%), 8 'Buy' (44.44%), 9 'Hold' (50.00%), 1 'Sell' (5.56%), and 0 'Strong Sell' (0.00%).

Medtronic Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 15, 2024	David Rescott	Robert W. Baird	$96.00	$90.01	6.65%	14.14%
Oct 10, 2024	Shagun Singh	RBC Capital	$105.00	$88.35	18.85%	24.84%
Oct 01, 2024	Vijay Kumar	Evercore ISI	$104.00	$90.03	15.52%	23.65%
Oct 01, 2024	Joanne Wuensch	Citigroup	$92.00	$90.03	2.19%	9.38%
Aug 21, 2024	David Roman	Goldman Sachs	$82.00	$86.40	-5.09%	-2.51%
Aug 21, 2024	Steven Lichtman	Oppenheimer	$94.00	$86.46	8.72%	11.76%
Aug 21, 2024	Matt O'Brien	Piper Sandler	$90.00	$85.38	5.41%	7.00%
Aug 21, 2024	Anthony Petrone	Mizuho Securities	$98.00	$86.38	13.45%	16.51%
Aug 21, 2024	Larry Biegelsen	Wells Fargo	$106.00	$85.38	24.15%	26.03%
Aug 20, 2024	Rick Wise	Stifel Nicolaus	$87.00	$85.38	1.90%	3.44%

Row per page

Go to

The latest Medtronic stock forecast, released on Oct 15, 2024 by David Rescott from Robert W. Baird, set a price target of $96.00, which represents a 6.65% increase from the stock price at the time of the forecast ($90.01), and a 14.14% increase from MDT last price ($84.11).

Medtronic Price Target by Period

	1M	3M	12M
# Anlaysts	-	9	15
Avg Price Target	-	$96.33	$95.07
Last Closing Price	$84.11	$84.11	$84.11
Upside/Downside	-100.00%	14.53%	13.03%

In the current month, the average price target of Medtronic stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Medtronic's last price of $84.11. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 10, 2024	RBC Capital	Sector Perform	Outperform	Upgrade
Oct 08, 2024	UBS	Underperform	Underperform	Hold
Oct 08, 2024	Wells Fargo	Sector Perform	Sector Perform	Hold
Oct 08, 2024	RBC Capital	Sector Perform	Sector Perform	Hold
Oct 01, 2024	Evercore ISI	Outperform	Outperform	Hold
Oct 01, 2024	Citigroup	Neutral	Neutral	Hold
Sep 12, 2024	Piper Sandler	Neutral	Neutral	Hold
Aug 22, 2024	Barclays	Overweight	Overweight	Hold
Aug 21, 2024	Oppenheimer	Perform	Perform	Hold
Aug 21, 2024	Piper Sandler	Overweight	Overweight	Hold

Row per page

Go to

Medtronic's last stock rating was published by RBC Capital on Oct 10, 2024. The company Upgrade its MDT rating from "Sector Perform" to "Outperform".

Medtronic Financial Forecast

Medtronic Revenue Forecast

	Apr 28	Jan 28	Oct 27	Jul 27	Apr 27	Jan 27	Oct 26	Jul 26	Apr 26	Jan 26	Oct 25	Jul 25	Apr 25	Jan 25	Oct 24	Jul 24	Apr 24	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$8.09B	$7.98B	$7.70B	$8.54B	$7.73B	$7.58B	$7.37B	$8.09B	$7.76B	$7.85B	$7.99B	$8.19B	$7.78B
Avg Forecast	$10.29B	$9.72B	$9.60B	$9.30B	$9.73B	$9.16B	$9.01B	$8.70B	$9.36B	$8.81B	$8.65B	$8.35B	$8.95B	$8.41B	$8.27B	$7.90B	$8.45B	$7.95B	$7.93B	$7.57B	$8.25B	$7.54B	$7.70B	$7.22B	$8.43B	$7.88B	$7.96B	$7.87B	$8.14B	$7.77B
High Forecast	$10.33B	$9.76B	$9.64B	$9.33B	$9.76B	$9.19B	$9.04B	$8.73B	$9.39B	$8.84B	$8.69B	$8.38B	$8.99B	$8.43B	$8.30B	$7.90B	$8.45B	$7.98B	$7.97B	$7.59B	$8.28B	$7.57B	$7.79B	$7.30B	$8.53B	$7.98B	$8.06B	$7.96B	$8.23B	$7.87B
Low Forecast	$10.23B	$9.66B	$9.55B	$9.24B	$9.67B	$9.10B	$8.96B	$8.65B	$9.30B	$8.76B	$8.60B	$8.30B	$8.90B	$8.37B	$8.23B	$7.90B	$8.45B	$7.91B	$7.86B	$7.52B	$8.21B	$7.49B	$7.65B	$7.17B	$8.37B	$7.83B	$7.91B	$7.82B	$8.08B	$7.72B
# Analysts	8	10	9	9	13	9	9	15	9	9	16	8	10	18	18	13	9	9	18	9	9	15	8	10	16	8	13	9	9	13
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.02%	1.01%	1.02%	1.04%	1.02%	0.99%	1.02%	0.96%	0.98%	0.99%	1.01%	1.01%	1.00%

Medtronic's average Quarter revenue forecast for Apr 24 based on 9 analysts is $8.45B, with a low forecast of $8.45B, and a high forecast of $8.45B. MDT's average Quarter revenue forecast represents a 4.47% increase compared to the company's last Quarter revenue of $8.09B (Jan 24).

Medtronic EBITDA Forecast

	Apr 28	Jan 28	Oct 27	Jul 27	Apr 27	Jan 27	Oct 26	Jul 26	Apr 26	Jan 26	Oct 25	Jul 25	Apr 25	Jan 25	Oct 24	Jul 24	Apr 24	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21
# Analysts	8	10	9	9	13	9	9	15	9	9	16	8	10	18	18	13	9	9	18	9	9	15	8	10	16	8	13	9	9	13
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.48B	$2.27B	$2.11B	$2.68B	$2.26B	$2.21B	$1.89B	$2.46B	$2.40B	$2.30B	$1.64B	$2.39B	$2.03B
Avg Forecast	$2.87B	$2.71B	$2.68B	$2.59B	$2.71B	$2.56B	$2.51B	$2.43B	$2.61B	$2.46B	$2.42B	$2.33B	$2.50B	$2.35B	$2.31B	$2.20B	$2.88B	$2.22B	$2.21B	$2.11B	$2.62B	$2.47B	$2.12B	$1.99B	$2.38B	$2.17B	$2.20B	$2.17B	$1.78B	$2.14B
High Forecast	$2.88B	$2.72B	$2.69B	$2.60B	$2.72B	$2.56B	$2.52B	$2.44B	$2.62B	$2.47B	$2.42B	$2.34B	$2.51B	$2.35B	$2.32B	$2.20B	$3.45B	$2.23B	$2.22B	$2.12B	$3.14B	$2.96B	$2.15B	$2.01B	$2.85B	$2.20B	$2.22B	$2.20B	$2.14B	$2.17B
Low Forecast	$2.86B	$2.70B	$2.66B	$2.58B	$2.70B	$2.54B	$2.50B	$2.41B	$2.60B	$2.44B	$2.40B	$2.32B	$2.48B	$2.34B	$2.30B	$2.20B	$2.30B	$2.21B	$2.19B	$2.10B	$2.09B	$1.98B	$2.11B	$1.98B	$1.90B	$2.16B	$2.18B	$2.16B	$1.43B	$2.13B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.67%	1.03%	1.00%	1.03%	0.91%	1.04%	0.95%	1.04%	1.10%	1.05%	0.75%	1.34%	0.95%

9 analysts predict MDT's average Quarter EBITDA for Apr 24 to be $2.88B, with a high of $3.45B and a low of $2.30B. This is 93.97% upper than Medtronic's previous annual EBITDA (Jan 24) of $1.48B.

Medtronic Net Income Forecast

	Apr 28	Jan 28	Oct 27	Jul 27	Apr 27	Jan 27	Oct 26	Jul 26	Apr 26	Jan 26	Oct 25	Jul 25	Apr 25	Jan 25	Oct 24	Jul 24	Apr 24	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21
# Analysts	8	10	9	9	13	9	9	15	9	9	16	8	10	18	18	13	9	9	18	9	9	15	8	10	16	8	13	9	9	13
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.32B	$909.00M	$791.00M	$1.18B	$1.22B	$427.00M	$929.00M	$1.49B	$1.48B	$1.32B	$763.00M	$1.36B	$1.27B
Avg Forecast	-	-	-	-	$2.27B	$2.00B	$1.89B	$1.76B	$2.16B	$1.90B	$1.80B	$1.72B	$2.08B	$1.78B	$1.62B	$1.55B	$1.78B	$1.64B	$1.53B	$1.44B	$1.62B	$1.41B	$1.66B	$1.45B	$1.47B	$1.77B	$1.67B	$1.71B	$1.12B	$1.49B
High Forecast	-	-	-	-	$2.29B	$2.01B	$1.90B	$1.77B	$2.17B	$1.91B	$1.80B	$1.73B	$2.09B	$1.81B	$1.65B	$1.55B	$2.13B	$1.64B	$1.56B	$1.49B	$1.94B	$1.69B	$1.68B	$1.47B	$1.76B	$1.80B	$1.70B	$1.74B	$1.34B	$1.52B
Low Forecast	-	-	-	-	$2.26B	$1.98B	$1.87B	$1.74B	$2.14B	$1.88B	$1.78B	$1.70B	$2.06B	$1.77B	$1.57B	$1.55B	$1.42B	$1.62B	$1.52B	$1.38B	$1.29B	$1.13B	$1.64B	$1.43B	$1.18B	$1.76B	$1.64B	$1.70B	$892.31M	$1.48B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.81%	0.59%	0.55%	0.73%	0.87%	0.26%	0.64%	1.01%	0.84%	0.79%	0.45%	1.22%	0.85%

Medtronic's average Quarter net income forecast for Apr 24 is $1.78B, with a range of $1.42B to $2.13B. MDT's average Quarter net income forecast represents a 34.47% increase compared to the company's last Quarter net income of $1.32B (Jan 24).

Medtronic SG&A Forecast

	Apr 28	Jan 28	Oct 27	Jul 27	Apr 27	Jan 27	Oct 26	Jul 26	Apr 26	Jan 26	Oct 25	Jul 25	Apr 25	Jan 25	Oct 24	Jul 24	Apr 24	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21
# Analysts	8	10	9	9	13	9	9	15	9	9	16	8	10	18	18	13	9	9	18	9	9	15	8	10	16	8	13	9	9	13
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.67B	$2.69B	$2.61B	$2.62B	$2.62B	$2.62B	$2.57B	$2.57B	$2.56B	$2.62B	$2.55B	$2.60B	$2.54B
Avg Forecast	$3.42B	$3.23B	$3.19B	$3.09B	$3.23B	$3.04B	$2.99B	$2.89B	$3.11B	$2.92B	$2.87B	$2.77B	$2.97B	$2.79B	$2.75B	$2.62B	$3.08B	$2.64B	$2.63B	$2.51B	$2.80B	$2.81B	$2.58B	$2.41B	$2.54B	$2.64B	$2.67B	$2.63B	$2.23B	$2.60B
High Forecast	$3.43B	$3.24B	$3.20B	$3.10B	$3.24B	$3.05B	$3.00B	$2.90B	$3.12B	$2.94B	$2.88B	$2.78B	$2.98B	$2.80B	$2.76B	$2.62B	$3.69B	$2.65B	$2.64B	$2.52B	$3.36B	$3.37B	$2.61B	$2.44B	$3.05B	$2.67B	$2.70B	$2.67B	$2.67B	$2.63B
Low Forecast	$3.40B	$3.21B	$3.17B	$3.07B	$3.21B	$3.02B	$2.97B	$2.87B	$3.09B	$2.91B	$2.86B	$2.76B	$2.95B	$2.78B	$2.73B	$2.62B	$2.46B	$2.62B	$2.61B	$2.50B	$2.24B	$2.25B	$2.56B	$2.40B	$2.03B	$2.62B	$2.65B	$2.62B	$1.78B	$2.58B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.01%	1.02%	1.04%	0.94%	0.93%	1.02%	1.06%	1.01%	0.97%	0.98%	0.97%	1.16%	0.98%

Medtronic's average Quarter SG&A projection for Apr 24 is $3.08B, based on 9 Wall Street analysts, with a range of $2.46B to $3.69B. The forecast indicates a 15.08% rise compared to MDT last annual SG&A of $2.67B (Jan 24).

Medtronic EPS Forecast

	Apr 28	Jan 28	Oct 27	Jul 27	Apr 27	Jan 27	Oct 26	Jul 26	Apr 26	Jan 26	Oct 25	Jul 25	Apr 25	Jan 25	Oct 24	Jul 24	Apr 24	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21
# Analysts	8	10	9	9	13	9	9	15	9	9	16	8	10	18	18	13	9	9	18	9	9	15	8	10	16	8	13	9	9	13
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$0.99	$0.68	$0.59	$0.89	$0.92	$0.32	$0.70	$1.11	$1.10	$0.98	$0.57	$1.01	$0.95
Avg Forecast	-	-	-	-	$1.75	$1.54	$1.46	$1.36	$1.67	$1.46	$1.38	$1.32	$1.60	$1.37	$1.25	$1.20	$1.45	$1.26	$1.18	$1.11	$1.55	$1.27	$1.28	$1.12	$1.56	$1.37	$1.29	$1.32	$1.42	$1.15
High Forecast	-	-	-	-	$1.76	$1.55	$1.46	$1.36	$1.67	$1.47	$1.39	$1.33	$1.61	$1.39	$1.27	$1.20	$1.51	$1.27	$1.20	$1.15	$1.62	$1.28	$1.30	$1.14	$1.63	$1.39	$1.31	$1.34	$1.44	$1.17
Low Forecast	-	-	-	-	$1.74	$1.53	$1.44	$1.35	$1.65	$1.45	$1.37	$1.31	$1.59	$1.36	$1.21	$1.20	$1.39	$1.25	$1.17	$1.07	$1.49	$1.26	$1.27	$1.10	$1.50	$1.35	$1.27	$1.31	$1.41	$1.14
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.78%	0.58%	0.53%	0.57%	0.72%	0.25%	0.62%	0.71%	0.81%	0.76%	0.43%	0.71%	0.83%

According to 9 Wall Street analysts, Medtronic's projected average Quarter EPS for Apr 24 is $1.45, with a low estimate of $1.39 and a high estimate of $1.51. This represents a 46.55% increase compared to MDT previous annual EPS of $0.99 (Jan 24).

Medtronic Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
TNDM	Tandem Diabetes Care	$30.15	$79.05	162.19%	Buy
ALGN	Align	$223.87	$421.00	88.06%	Buy
MDT	Medtronic	$84.11	$107.91	28.30%	Hold
EW	Edwards Lifesciences	$69.54	$88.04	26.60%	Buy
ZBH	Zimmer Biomet	$109.27	$133.78	22.43%	Hold
ABT	Abbott Laboratories	$115.93	$126.45	9.07%	Buy
DXCM	DexCom	$75.24	$81.36	8.13%	Buy
PODD	Insulet	$266.58	$274.00	2.78%	Buy
SYK	Stryker	$385.68	$317.96	-17.56%	Buy

MDT Forecast FAQ

Is Medtronic a good buy?

No, according to 18 Wall Street analysts, Medtronic (MDT) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 44.44% of MDT's total ratings.

What is MDT's price target?

Medtronic (MDT) average price target is $107.91 with a range of $80 to $165, implying a 28.30% from its last price of $84.11. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Medtronic stock go up soon?

According to Wall Street analysts' prediction for MDT stock, the company can go up by 28.30% (from the last price of $84.11 to the average price target of $107.91), up by 96.17% based on the highest stock price target, and down by -4.89% based on the lowest stock price target.

Can Medtronic stock reach $130?

MDT's highest twelve months analyst stock price target of $165 supports the claim that Medtronic can reach $130 in the near future.

What are Medtronic's analysts' financial forecasts?

Medtronic's analysts financial forecasts for the fiscal year (Apr 2027) are as follows: average revenue is $36.59B (high $36.72B, low $36.37B), average EBITDA is $10.21B (high $10.25B, low $10.15B), average net income is $7.92B (high $7.95B, low $7.86B), average SG&A $12.15B (high $12.19B, low $12.07B), and average EPS is $6.11 (high $6.14, low $6.06). MDT's analysts financial forecasts for the fiscal year (Apr 2028) are as follows: average revenue is $38.92B (high $39.05B, low $38.68B), average EBITDA is $10.86B (high $10.9B, low $10.8B), average net income is $0 (high $0, low $0), average SG&A $12.92B (high $12.96B, low $12.84B), and average EPS is $0 (high $0, low $0).

Did the MDT's actual financial results beat the analysts' financial forecasts?

Based on Medtronic's last annual report (Apr 2023), the company's revenue was $31.23B, beating the average analysts forecast of $30.71B by 1.69%. Apple's EBITDA was $9.04B, missing the average prediction of $9.2B by -1.70%. The company's net income was $3.76B, missing the average estimation of $6.13B by -38.72%. Apple's SG&A was $10.42B, missing the average forecast of $10.6B by -1.72%. Lastly, the company's EPS was $2.85, missing the average prediction of $5.22 by -45.42%. In terms of the last quarterly report (Jan 2024), Medtronic's revenue was $8.09B, beating the average analysts' forecast of $7.95B by 1.71%. The company's EBITDA was $1.48B, missing the average prediction of $2.22B by -33.18%. Medtronic's net income was $1.32B, missing the average estimation of $1.64B by -19.18%. The company's SG&A was $2.67B, beating the average forecast of $2.64B by 1.26%. Lastly, the company's EPS was $0.99, missing the average prediction of $1.26 by -21.53%